ClinicalTrials.Veeva

Menu

Sodiumhexametaphosphate as Pulp Capping Material for Primary Teeth

M

Minia University

Status

Not yet enrolling

Conditions

Pulp Disease, Dental

Treatments

Other: Pulp therapy
Other: MTA
Drug: Sodiumhexametaphosphate

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Sodiumhexametaphosphate will be tested as pulp capping material in comparison to MTA for primary teeth pulp therapy

Enrollment

100 estimated patients

Sex

All

Ages

4 to 10 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • physical healthy children
  • cooperative children
  • primary molar with deep carious lesion
  • absence of pain or transient momentary pain

Exclusion criteria

  • Uncooperative children
  • children with systemic disorders
  • periapical lesions
  • sever pain

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups

Sodiumhexametaphosphate
Experimental group
Treatment:
Drug: Sodiumhexametaphosphate
Other: Pulp therapy
MTA
Active Comparator group
Treatment:
Other: MTA
Other: Pulp therapy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems